Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clene Inc. - Common Stock (NQ:CLNN)

2.690 -0.360 (-11.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,383
Open 2.940
Bid (Size) 2.660 (4)
Ask (Size) 2.720 (3)
Prev. Close 3.050
Today's Range 2.685 - 3.040
52wk Range 2.570 - 9.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Study Suggests Possible Link Between ADHD and Heightened Dementia Risk
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Share CNM-Au8(R) Progress at Jones Las Vegas Conference
Via Investor Brand Network
Exposures Product Safety

Performance

YTD
-50.1%
-50.1%
1 Month
-38.9%
-38.9%
3 Month
-49.6%
-49.6%
6 Month
-49.2%
-49.2%
1 Year
-68.2%
-68.2%

More News

Read More
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference on April 9
Via Investor Brand Network
Clene Inc.’s (NASDAQ: CLNN) Q1 Virtual Investor Summit Presentation Available for On-Demand Viewing
Via Investor Brand Network
New Study Finds Possible Explanation for Higher Parkinson’s Prevalence in Men
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Las Vegas Technology and Innovation Conference
Via Investor Brand Network
Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
Via TheNewswire.com
Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
Via NewMediaWire
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Plans 2025 NDA Submission Following Positive ALS Trial Data
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval
Via Investor Brand Network
Exposures Product Safety
Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Delivers Significant Survival Benefits in New Analyses of Healey ALS Platform Trial Data
Via Investor Brand Network
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
Via ACCESS Newswire
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Reports CNM-Au8 Significantly Improves Survival in ALS Patients
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Present CNM-Au8(R) Updates at 37th Annual Roth Conference
Via Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Collaborates to Support Potential Accelerated Pathway for ALS Treatment Candidate
Via Investor Brand Network
Exposures Product Safety
Bacterial Imbalances Have a Link to Multiple Sclerosis, Study Finds
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Participate in 37th Annual Roth Conference
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Highlight Latest Achievements, Next Steps for CNM-Au8(R), at Q1 Virtual Investor Summit on March 11
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Leverages APST’s NfL Database to Support FDA-Recommended Analyses for ALS Drug
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO and CFO to Present at Investor Summit Virtual on March 11
Via Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO and CFO to Present at Investor Summit Virtual on March 11
Via Investor Brand Network
Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11
Via ACCESS Newswire
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process
Via Investor Brand Network
Exposures Product Safety
New Study to Explore the Link Between Sleep Disorder and Parkinson’s
Via Investor Brand Network
IBN Coverage: Clene (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS
Via NewMediaWire

Frequently Asked Questions

Is Clene Inc. - Common Stock publicly traded?
Yes, Clene Inc. - Common Stock is publicly traded.
What exchange does Clene Inc. - Common Stock trade on?
Clene Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Clene Inc. - Common Stock?
The ticker symbol for Clene Inc. - Common Stock is CLNN on the Nasdaq Stock Market
What is the current price of Clene Inc. - Common Stock?
The current price of Clene Inc. - Common Stock is 2.690
When was Clene Inc. - Common Stock last traded?
The last trade of Clene Inc. - Common Stock was at 04/04/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.